We are live on ! Find out more
IART icon

Integra LifeSciences
IART

278 hedge funds and large institutions have $4.71B invested in Integra LifeSciences in 2022 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 112 increasing their positions, 92 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more call options, than puts

Call options by funds: $10.2M | Put options by funds: $7.96M

22% more repeat investments, than reductions

Existing positions increased: 112 | Existing positions reduced: 92

21% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 24

0% more funds holding

Funds holding: 277 → 278 (+1)

1.7% less ownership

Funds ownership: 91.4% → 89.7% (-1.7%)

9% less capital invested

Capital invested by funds: $5.16B → $4.71B (-$449M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
278
Holders Change
+1
Holders Change %
+0.36%
% of All Funds
4.38%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
29
Increased
112
Reduced
92
Closed
24
Calls
$10.2M
Puts
$7.96M
Net Calls
+$2.23M
Net Calls Change
+$12.9M

Top Buyers

1
Two Sigma Investments
Two Sigma Investments
New York
+$18.6M
2
Millennium Management
Millennium Management
New York
+$15.2M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$15M
4
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$11.2M
5
Citadel Advisors
Citadel Advisors
Florida
+$10.2M

Top Sellers

1
Wellington Management Group
Wellington Management Group
Massachusetts
-$153M
2
Capital Research Global Investors
Capital Research Global Investors
California
-$92.3M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$30.6M
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$18.2M
5
HRCM
Hood River Capital Management
Florida
-$17.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
SIC
301
SJS Investment Consulting
Ohio
– +$132 +2 New
9 10 11 12
13

IART Hedge Fund Activity: Q1 2022 in Review

278 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q1 2022, worth a combined $4.71B — down 8.7% from $5.16B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new IART positions and 24 closed out — a net gain of 5 holders — while 112 added to existing stakes and 92 trimmed.

The largest buyer was Two Sigma Investments, opening a new position worth an estimated $18.6M. The largest seller was Wellington Management Group, cutting an estimated $153M.

  • 278 institutional investors held Integra LifeSciences (IART) as of Q1 2022, up from 277 in Q4 2021.
  • Funds reported $4.71B of Integra LifeSciences stock for Q1 2022, down 8.7% quarter-over-quarter.
  • 29 funds opened new Integra LifeSciences positions in Q1 2022 and 24 closed out, a net change of +5 holders.
  • The largest Integra LifeSciences buyer in Q1 2022 was Two Sigma Investments, an estimated $18.6M added.
  • The largest Integra LifeSciences seller in Q1 2022 was Wellington Management Group, an estimated $153M sold.

Based on aggregated 13F filings for Q1 2022.